These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 17320006)
1. An analysis of the population genetics of potential multi-drug resistance in Wuchereria bancrofti due to combination chemotherapy. Schwab AE; Churcher TS; Schwab AJ; Basáñez MG; Prichard RK Parasitology; 2007 Jul; 134(Pt 7):1025-40. PubMed ID: 17320006 [TBL] [Abstract][Full Text] [Related]
2. Population genetics of concurrent selection with albendazole and ivermectin or diethylcarbamazine on the possible spread of albendazole resistance in Wuchereria bancrofti. Schwab AE; Churcher TS; Schwab AJ; Basáñez MG; Prichard RK Parasitology; 2006 Nov; 133(Pt 5):589-601. PubMed ID: 16834821 [TBL] [Abstract][Full Text] [Related]
3. Detection of benzimidazole resistance-associated mutations in the filarial nematode Wuchereria bancrofti and evidence for selection by albendazole and ivermectin combination treatment. Schwab AE; Boakye DA; Kyelem D; Prichard RK Am J Trop Med Hyg; 2005 Aug; 73(2):234-8. PubMed ID: 16103581 [TBL] [Abstract][Full Text] [Related]
4. Clinical efficacy assessment of the albendazole-ivermectin combination in lambs parasitized with resistant nematodes. Entrocasso C; Alvarez L; Manazza J; Lifschitz A; Borda B; Virkel G; Mottier L; Lanusse C Vet Parasitol; 2008 Aug; 155(3-4):249-56. PubMed ID: 18571329 [TBL] [Abstract][Full Text] [Related]
5. An allele specific PCR assay for screening for drug resistance among Wuchereria bancrofti populations in India. Hoti SL; Dhamodharan R; Subramaniyan K; Das PK Indian J Med Res; 2009 Aug; 130(2):193-9. PubMed ID: 19797818 [TBL] [Abstract][Full Text] [Related]
6. Is anthelmintic resistance a threat to the program to eliminate lymphatic filariasis? McCarthy J Am J Trop Med Hyg; 2005 Aug; 73(2):232-3. PubMed ID: 16103580 [No Abstract] [Full Text] [Related]
7. Efficacy of a single-dose treatment with 300 mg diethylcarbamazine and a combination of 400 mg albendazole in reduction of Wuchereria bancrofti antigenemia and concomitant geohelminths in Myanmar migrants in Southern Thailand. Yongyuth P; Koyadun S; Jaturabundit N; Sampuch A; Bhumiratana A J Med Assoc Thai; 2006 Aug; 89(8):1237-48. PubMed ID: 17048435 [TBL] [Abstract][Full Text] [Related]
8. The effect of six rounds of single dose mass treatment with diethylcarbamazine or ivermectin on Wuchereria bancrofti infection and its implications for lymphatic filariasis elimination. Ramaiah KD; Vanamail P; Pani SP; Yuvaraj J; Das PK Trop Med Int Health; 2002 Sep; 7(9):767-74. PubMed ID: 12225508 [TBL] [Abstract][Full Text] [Related]
9. Heterogeneous response of Wuchereria bancrofti-infected persons to diethylcarbamazine (DEC) and its implications for the Global Programme to Eliminate Lymphatic Filariasis (GPELF). Sankari T; Subramanian S; Hoti SL; Pani SP; Jambulingam P; Das PK Parasitol Res; 2021 Jan; 120(1):311-319. PubMed ID: 33146778 [TBL] [Abstract][Full Text] [Related]
10. The impact of six rounds of single-dose mass administration of diethylcarbamazine or ivermectin on the transmission of Wuchereria bancrofti by Culex quinquefasciatus and its implications for lymphatic filariasis elimination programmes. Ramaiah KD; Das PK; Vanamail P; Pani SP Trop Med Int Health; 2003 Dec; 8(12):1082-92. PubMed ID: 14641843 [TBL] [Abstract][Full Text] [Related]
11. Influence of anti-filarial chemotherapy strategies on the genetic structure of Wuchereria bancrofti populations. Ramasamy D; Laxmanappa HS; Sharma R; Das MK Mem Inst Oswaldo Cruz; 2011 Mar; 106(2):240-7. PubMed ID: 21537687 [TBL] [Abstract][Full Text] [Related]
12. Efficacy, Safety, and Pharmacokinetics of Coadministered Diethylcarbamazine, Albendazole, and Ivermectin for Treatment of Bancroftian Filariasis. Thomsen EK; Sanuku N; Baea M; Satofan S; Maki E; Lombore B; Schmidt MS; Siba PM; Weil GJ; Kazura JW; Fleckenstein LL; King CL Clin Infect Dis; 2016 Feb; 62(3):334-341. PubMed ID: 26486704 [TBL] [Abstract][Full Text] [Related]
13. Could ivermectin have a synergic effect with albendazole in hydatidosis therapy? Casado N; Moreno MJ; Urrea-París MA; Rodríguez-Caabeiro F Parasitol Res; 2002 Feb; 88(2):153-9. PubMed ID: 11936505 [TBL] [Abstract][Full Text] [Related]
14. Model-based analysis of trial data: microfilaria and worm-productivity loss after diethylcarbamazine-albendazole or ivermectin-albendazole combination therapy against Wuchereria bancrofti. de Kraker ME; Stolk WA; van Oortmarssen GJ; Habbema JD Trop Med Int Health; 2006 May; 11(5):718-28. PubMed ID: 16640625 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of pharmacological interactions after administration of a levamisole, albendazole and ivermectin triple combination in lambs. Suarez G; Alvarez L; Castells D; Moreno L; Fagiolino P; Lanusse C Vet Parasitol; 2014 Mar; 201(1-2):110-9. PubMed ID: 24462508 [TBL] [Abstract][Full Text] [Related]
16. Imported bancroftian filariasis: diethylcarbamazine response and benzimidazole susceptibility of Wuchereria bancrofti in dynamic cross-border migrant population targeted by the National Program to Eliminate Lymphatic Filariasis in South Thailand. Bhumiratana A; Pechgit P; Koyadun S; Siriaut C; Yongyuth P Acta Trop; 2010 Feb; 113(2):121-8. PubMed ID: 19835831 [TBL] [Abstract][Full Text] [Related]
17. Comparative analysis of a chemotherapy effect on the cuticular surface of Wuchereria bancrofti adult worms in vivo. Oliveira-Menezes A; Lins R; Norões J; Dreyer G; Lanfredi RM Parasitol Res; 2007 Oct; 101(5):1311-7. PubMed ID: 17622561 [TBL] [Abstract][Full Text] [Related]
18. Filamentation temperature-sensitive protein Z (FtsZ) of Wolbachia, endosymbiont of Wuchereria bancrofti: a potential target for anti-filarial chemotherapy. Sharma R; Hoti SL; Vasuki V; Sankari T; Meena RL; Das PK Acta Trop; 2013 Mar; 125(3):330-8. PubMed ID: 23262214 [TBL] [Abstract][Full Text] [Related]
19. Effect of a single dose of diethylcarbamazine, albendazole or both on the clearance of Wuchereria bancrofti microfilariae and antigenaemia among microfilaria carriers: a randomized trial. Hoti SL; Pani SP; Vanamail P; Athisaya Mary K; Das LK; Das PK Natl Med J India; 2010; 23(2):72-6. PubMed ID: 20925201 [TBL] [Abstract][Full Text] [Related]
20. Vector control complements mass drug administration against bancroftian filariasis in Tirukoilur, India. Sunish IP; Rajendran R; Mani TR; Munirathinam A; Dash AP; Tyagi BK Bull World Health Organ; 2007 Feb; 85(2):138-45. PubMed ID: 17308735 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]